Phase II trial of roxadustat for chemotherapy-induced anemia meets primary efficacy endpoint Aug. 25, 2021 No Comments
InnoCare receives NMPA clearance for phase II study of orelabrutinib in ITP Aug. 11, 2021 No Comments
First-in-human study investigates HJV inhibitor DISC-0974 for anemia of inflammation July 28, 2021 No Comments
RSS